Viatronix's V3D colon gets FDA approval
3D imaging software provider Viatronix Inc. received FDA approval this week for its V3D-Colon system for the detection of colon cancer.
V3D offers patients a non-invasive alternative screening method for colon cancer. It requires no sedation and the patient has a less harsh preparation by allowing a low residue diet, because the system's software electronically removes any tagged stool remnants of liquid from the colon.
Clinicians are offered improved workflow capabilities for manipulating and analyzing the scanned images with a high-resolution visualization system. In addition, the company says the system permits users to "fly-through" automatically, as well as manually interact, turn, zoom and rotate the images in a "live" volume rendering environment.
V3D offers patients a non-invasive alternative screening method for colon cancer. It requires no sedation and the patient has a less harsh preparation by allowing a low residue diet, because the system's software electronically removes any tagged stool remnants of liquid from the colon.
Clinicians are offered improved workflow capabilities for manipulating and analyzing the scanned images with a high-resolution visualization system. In addition, the company says the system permits users to "fly-through" automatically, as well as manually interact, turn, zoom and rotate the images in a "live" volume rendering environment.